Stay updated on Avicanna Press Releases
Sign up to get notified when there's something new on the Avicanna Press Releases page.

Latest updates to the Avicanna Press Releases page
- CheckyesterdayChange DetectedThe webpage has been updated to reflect the announcement of Avicanna's Annual General Meeting results on June 30, 2025, replacing the previous announcement dated April 14, 2025, which included the company's full year 2024 results.SummaryDifference7%
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAvicanna has announced significant updates, including the sponsorship of a clinical study for osteoarthritis pain and reporting its first profitable quarter for Q1 2025. Additionally, the company has had a Management Cease Trade Order revoked.SummaryDifference7%
- Check22 days agoNo Change Detected
- Check30 days agoNo Change Detected
- Check66 days agoChange DetectedAvicanna has announced the revocation of a management cease trade order, which is a significant update regarding the company's regulatory status.SummaryDifference6%
- Check80 days agoChange DetectedThe page has been updated to include Avicanna's full year 2024 audited financial statement, while a previous announcement regarding a management cease trade order has been removed.SummaryDifference7%
- Check88 days agoChange DetectedThe Ontario Securities Commission has approved Avicanna's application for a management cease trade order, and the company has announced its 5th Medical Symposium on Cannabinoid-based Medicine, both dated April 7, 2025.SummaryDifference8%
- Check95 days agoChange DetectedAvicanna has announced a full-year earnings conference call and a collaboration with Vectura Fertin Pharma, while previous reports on the completion of product deliveries and Q3 2024 results have been removed.SummaryDifference1%
Stay in the know with updates to Avicanna Press Releases
Enter your email address, and we'll notify you when there's something new on the Avicanna Press Releases page.